Literature DB >> 17174475

No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes.

Cecilia Huerta1, Elena Sánchez-Ferrero, Eliecer Coto, Marta Blázquez, René Ribacoba, Luis M Guisasola, Carlos Salvador, Victoria Alvarez.   

Abstract

Nitric oxide synthases (NOS) and mitochondrial DNA-polymorphisms have been associated with the risk of developing Parkinson's disease (PD). In this report, we genotyped 450 PD-patients and 200 controls for three polymorphisms in the endothelial, inducible and neuronal NOS-genes, and for the T4336C and A10398G mitochondrial DNA-polymorphisms. None of the eNOS (intron 4 VNTR), iNOS (exon 22 A/G), or nNOS (exon 29T/C) were significantly associated with PD. Mitochondrial 4336C increased the PD-risk among women (OR=6.13), while the 10398G had a protective effect (OR=0.52). We did not find significantly interactions between the NOS and mitochondrial polymorphisms in the risk for PD in our population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174475     DOI: 10.1016/j.neulet.2006.11.044

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Statin use and Parkinson's disease in Denmark.

Authors:  Beate Ritz; Angelika D Manthripragada; Lei Qian; Eva Schernhammer; Lene Wermuth; Jorgen Olsen; Soren Friis
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 2.  Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?

Authors:  Satya Prakash Gupta; Sharawan Yadav; Naveen Kumar Singhal; Manindra Nath Tiwari; Sarad Kumar Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2013-07-31       Impact factor: 5.590

Review 3.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

4.  Effect of isoflurane + N2O inhalation and propofol + fentanyl anesthesia on myocardial function as assessed by cardiac troponin, caspase-3, cyclooxygenase-2 and inducible nitric oxide synthase expression.

Authors:  Zhuanghui Zhu; Shuanglian Yi; Zhonggui Shan; Hongwei Guo; Shaofan Ke
Journal:  Exp Ther Med       Date:  2017-08-25       Impact factor: 2.447

5.  Association of Polymorphism of Neuronal Nitric Oxide Synthase Gene with Risk to Parkinson's Disease.

Authors:  Satya Prakash Gupta; Ritul Kamal; Sarad Kumar Mishra; Maneesh Kumar Singh; Rakesh Shukla; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

6.  Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease.

Authors:  Dana B Hancock; Eden R Martin; Jeffery M Vance; William K Scott
Journal:  Neurogenetics       Date:  2008-07-29       Impact factor: 2.660

Review 7.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Authors:  Hironori Yokoyama; Hayato Kuroiwa; Ryohei Yano; Tsutomu Araki
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

8.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

9.  Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.

Authors:  Joanne Clark; Sonika Reddy; Kangni Zheng; Rebecca A Betensky; David K Simon
Journal:  BMC Med Genet       Date:  2011-05-19       Impact factor: 2.103

10.  Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?

Authors:  Joanne Clark; Ying Dai; David K Simon
Journal:  Parkinsons Dis       Date:  2011-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.